Literature DB >> 18623109

A modified grading system for post-hepatectomy metastatic liver cancer originating from colorectal carcinoma.

Atsushi Nanashima1, Yorihisa Sumida, Takafumi Abo, Syuuichi Tobinaga, Hiroaki Takeshita, Shigekazu Hidaka, Toru Yasutake, Takeshi Nagayasu, Mariko Mine, Terumitsu Sawai.   

Abstract

BACKGROUND AND OBJECTIVES: There is no appropriate grading system for prediction of survival of patients with metastatic liver cancer (MLC) from colorectal carcinoma. We propose the modified grading system for MLC from the present Japanese system.
METHODS: We compared predictive accuracies of survival of 121 Japanese MLC patients of five systems, including clinical risk score (CRS) proposed by Memorial-Sloan-Kettering-Cancer-Center, original H-number (OHN) by Japanese Society for Cancer of the Colon and Rectum, revised H-number (RHN) and Grade by the same society (GJSCCR), and our modified Grade (MGJSCCR) based on OHN and presence of primary lymph node metastasis.
RESULTS: Univariate analysis showed that discrimination of both disease-free and overall survival rates was significant for CRS, OHN and MGJSCCR (P < 0.05) but not for RHN and GJSCCR. Multivariate analysis showed CRS and MGJSCCR as the best systems for predicting disease-free and overall survival according to disease stage, for which Akaike information criteria (AIC) value was the lowest (423.7 and 313.9, hazard ratio 1.73 and 1.47, respectively for CRS, 423.9 and 313.5, hazard ratio 1.75 and 1.69, respectively for MGJSCCR; P < 0.05).
CONCLUSIONS: The simpler system of MGJSCCR is a better predictive grading system of prognosis of MLC patients who had undergone hepatic resection. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18623109     DOI: 10.1002/jso.21114

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  2 in total

Review 1.  Personalizing prognosis in colorectal cancer: A systematic review of the quality and nature of clinical prognostic tools for survival outcomes.

Authors:  Alyson L Mahar; Carolyn Compton; Susan Halabi; Kenneth R Hess; Martin R Weiser; Patti A Groome
Journal:  J Surg Oncol       Date:  2017-08-02       Impact factor: 3.454

2.  Novel methods for clinical risk stratification in patients with colorectal liver metastases.

Authors:  Ki-Yeol Kim; Nam Kyu Kim; In-Ho Cha; Joong Bae Ahn; Jin Sub Choi; Gi-Hong Choi; Joon Suk Lim; Kang Young Lee; Seung Hyuk Baik; Byung Soh Min; Hyuk Hur; Jae Kyung Roh; Sang Joon Shin
Journal:  Cancer Res Treat       Date:  2014-09-11       Impact factor: 4.679

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.